Zelnecirnon

N/A

Report date: 2025/11/24 11:49:05
NME

Base Information

Drug NameZelnecirnon
Drug Alias NameFLX-193RPT-193
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 4 antagonists
TargetsC-C chemokine receptor type 4
Therapy Area/IndicationsDermatitis, AtopicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRapt Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRapt Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicAsthma

Other Information

ATC CodeN/A
Related LinksN/A